PREVOZNIK MICHAEL E
SEC CIK 1222679 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DGX | Quest Diagnostics | SVP, GC | 60.2K | — | $33.84M | 52 | 2022-02-23 | 2026-08-28 |
Most active insiders at DGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Davis J. E. | CEO, Pres, Dir | — | $17.08M |
| 2 | Doherty Catherine T. | EVP, Regional Businesses | — | $6.96M |
| 3 | PREVOZNIK MICHAEL E | SVP, GC | — | $6.69M |
| 4 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | — | $2.17M |
| 5 | Plewman Patrick | SVP for Diagnostic Services | — | $2.03M |
| 6 | DELANEY MARK E | SVP, Chief Commercial Off | — | $1.86M |
| 7 | PFEIFFER GARY M | Dir | — | $270.3K |
| 8 | Gregg Vicky B | Dir | — | $239.7K |
| 9 | Lassiter Wright III | Dir | — | — |
| 10 | Deppe Michael J | SVP, CAO, Corp. Ctrl | — | — |
Transactions 52
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-31 16:37 | 2026-08-28 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | M - OptEx | $112.17 | +22.7K | 60.2K | +60% | +$2.54M |
| DMT | 2026-08-31 16:37 | 2026-08-28 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | S - Sale+OE | $243.11 | -22.7K | 37.6K | -38% | -$5.51M |
| DT | 2026-08-31 16:37 | 2026-08-28 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | G - Gift | $0.00 | -1,000 | 36.6K | -3% | $0 |
| 2026-03-06 | 2026-03-04 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $204.86 | -3,354 | 41.4K | -7% | -$687.1K | |
| 2026-03-06 | 2026-03-04 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $204.86 | +7,232 | 44.8K | +19% | +$1.48M | |
| 2026-03-06 | 2026-03-05 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $206.21 | -3,878 | 37.6K | -9% | -$799.7K | |
| 2026-03-04 | 2026-03-03 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $207.73 | -526 | 37.6K | -1% | -$109.3K | |
| 2026-03-04 | 2026-03-02 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $204.86 | -288 | 38.1K | -0.8% | -$59.0K | |
| DM | 2026-02-20 | 2026-02-18 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $208.39 | -648 | 39.8K | -2% | -$135.0K |
| D | 2026-02-20 | 2026-02-18 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $0.00 | +2,013 | 40.1K | +5% | $0 |
| D | 2026-02-20 | 2026-02-19 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $204.83 | -1,111 | 38.4K | -3% | -$227.6K |
| D | 2025-09-30 | 2025-09-26 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | M - OptEx | $103.57 | +227 | 38.3K | +0.6% | +$23.5K |
| DM | 2025-09-30 | 2025-09-26 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | S - Sale+OE | $188.13 | -227 | 38.1K | -0.6% | -$42.7K |
| DM | 2025-09-25 | 2025-09-23+ | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | S - Sale+OE | $187.12 | -28.5K | 38.1K | -43% | -$5.33M |
| DM | 2025-09-25 | 2025-09-23+ | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | M - OptEx | $103.57 | +28.5K | 38.3K | +290% | +$2.95M |
| 2025-03-19 | 2025-03-17 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $170.00 | -4,643 | 38.1K | -11% | -$789.3K | |
| 2025-03-05 | 2025-03-04 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $173.74 | +8,549 | 46.7K | +22% | +$1.49M | |
| 2025-03-05 | 2025-03-04 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $175.79 | -592 | 38.1K | -2% | -$104.1K | |
| M | 2025-03-05 | 2025-03-03+ | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $173.74 | -4,228 | 42.8K | -9% | -$734.6K |
| 2025-02-28 | 2025-02-26 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $171.75 | -286 | 39.6K | -0.7% | -$49.1K | |
| 2025-02-28 | 2025-02-27 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $172.61 | -528 | 39.0K | -1% | -$91.1K | |
| 2025-02-21 | 2025-02-19 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $169.71 | -374 | 40.4K | -0.9% | -$63.5K | |
| 2025-02-21 | 2025-02-20 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $170.99 | -604 | 39.8K | -1% | -$103.3K | |
| D | 2025-02-14 | 2025-02-12 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $0.00 | +2,345 | 40.8K | +6% | $0 |
| D | 2024-12-02 | 2024-11-29 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | M - OptEx | $86.63 | +35.1K | 73.6K | +91% | +$3.04M |
| DM | 2024-12-02 | 2024-11-29 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | S - Sale+OE | $163.07 | -35.1K | 38.5K | -48% | -$5.73M |
| D | 2024-09-03 | 2024-08-29 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | S - Sale+OE | $154.97 | -32.6K | 38.5K | -46% | -$5.04M |
| D | 2024-09-03 | 2024-08-29 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | M - OptEx | $95.80 | +32.6K | 71.0K | +85% | +$3.12M |
| M | 2024-03-01 | 2024-02-28 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $126.36 | -861 | 44.5K | -2% | -$108.8K |
| 2024-03-01 | 2024-02-29 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $125.88 | -5,611 | 38.5K | -13% | -$706.3K | |
| 2024-02-27 | 2024-02-23 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $125.02 | +7,569 | 47.8K | +19% | +$946.3K | |
| 2024-02-27 | 2024-02-23 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $125.02 | -2,825 | 45.0K | -6% | -$353.2K | |
| 2024-02-23 | 2024-02-21 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $125.02 | -407 | 40.9K | -1.0% | -$50.9K | |
| 2024-02-23 | 2024-02-22 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $126.14 | -661 | 40.2K | -2% | -$83.4K | |
| D | 2024-02-16 | 2024-02-14 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $0.00 | +2,935 | 41.3K | +8% | $0 |
| 2023-03-08 | 2023-03-06 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $147.86 | +8,595 | 47.1K | +22% | +$1.27M | |
| 2023-03-08 | 2023-03-07 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $140.55 | -4,754 | 38.5K | -11% | -$668.2K | |
| 2023-03-08 | 2023-03-06 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $147.86 | -3,841 | 43.3K | -8% | -$567.9K | |
| 2023-03-03 | 2023-03-01 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $140.69 | -320 | 39.1K | -0.8% | -$45.0K | |
| 2023-03-03 | 2023-03-02 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $138.54 | -593 | 38.5K | -2% | -$82.2K | |
| D | 2023-02-27 | 2023-02-23 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $0.00 | +2,442 | 40.9K | +6% | $0 |
| D | 2023-02-27 | 2023-02-23 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $147.86 | -811 | 38.4K | -2% | -$119.9K |
| D | 2023-02-27 | 2023-02-24 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $141.42 | -1,415 | 39.4K | -3% | -$200.1K |
| D | 2022-05-19 | 2022-05-17 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | M - OptEx | $66.51 | +50.6K | 89.8K | +129% | +$3.37M |
| D | 2022-05-19 | 2022-05-17 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | S - Sale+OE | $139.97 | -50.6K | 39.2K | -56% | -$7.08M |
| 2022-03-09 | 2022-03-07 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $130.09 | +11.5K | 50.8K | +29% | +$1.50M | |
| 2022-03-09 | 2022-03-08 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $135.21 | -6,228 | 39.2K | -14% | -$842.1K | |
| 2022-03-09 | 2022-03-07 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $130.09 | -5,316 | 45.5K | -10% | -$691.6K | |
| 2022-03-02 | 2022-02-28 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $130.00 | -661 | 39.2K | -2% | -$85.9K | |
| D | 2022-02-28 | 2022-02-24 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $0.00 | +2,741 | 39.9K | +7% | $0 |
| D | 2022-02-28 | 2022-02-24 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $126.26 | -1,669 | 37.1K | -4% | -$210.7K |
| M | 2022-02-25 | 2022-02-23 | DGX | Quest Diagnostics | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $130.13 | -1,339 | 38.8K | -3% | -$174.2K |
Purchase Sale Sale after option exercise All abbreviations